| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.14 | 5e-05 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.13 | 0.003 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.005 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |